The role of pleurodesis in respiratory diseases

被引:11
作者
Mercer, Rachel M. [1 ,2 ]
Hassan, Maged [1 ,2 ,3 ]
Rahman, Najib M. [1 ,2 ,4 ]
机构
[1] Univ Oxford, Oxford Resp Trials Unit, Oxford, England
[2] Oxford Univ Hosp NHS Trust, Oxford Ctr Resp Med, Oxford, England
[3] Alexandria Univ, Chest Dis Dept, Fac Med, Alexandria, Egypt
[4] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
Pleurodesis; pleural effusion; pneumothorax; surgery; thoracoscopy; indwelling pleural catheter; talc; MALIGNANT PLEURAL EFFUSIONS; PRIMARY SPONTANEOUS PNEUMOTHORAX; BLOOD PATCH PLEURODESIS; TALC SLURRY PLEURODESIS; CHEMICAL PLEURODESIS; CHEST TUBE; LUNG TRANSPLANTATION; INTRAPLEURAL TALC; RANDOMIZED-TRIAL; CYSTIC-FIBROSIS;
D O I
10.1080/17476348.2018.1445971
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Pleurodesis is used to obliterate the pleural space, most commonly in patients with symptomatic malignant pleural effusions but also in patients with benign effusions or pneumothorax.Areas covered: Traditionally, chemical pleurodesis has been undertaken at thoracoscopy or using instillation of a slurry through a chest drain. The optimum method of achieving pleurodesis, whether surgical or medical, has yet to be proven. Evidence in the different disease areas will be reviewed, along with ongoing trial evidence, which may change practice.Expert commentary: Newer methods of achieving pleurodesis are being introduced. Studies have shown that instilling sclerosing agents via an indwelling pleural catheter or introducing drug-eluting catheters are safe and effective ways of inducing pleurodesis. There is evidence that pleurodesis might increase in survival, especially after pleural infection, possibly due to activation of the immune system. Multiple studies are currently underway to answer some of these questions and the future landscape may be very different from the present.
引用
收藏
页码:323 / 334
页数:12
相关论文
共 100 条
[1]   Efficacy and safety of iodopovidone in chemical pleurodesis: A meta-analysis of observational studies [J].
Agarwal, Ritesh ;
Aggarwal, Ashutosh N. ;
Gupta, Dheeraj ;
Jindal, Surinder K. .
RESPIRATORY MEDICINE, 2006, 100 (11) :2043-2047
[2]   Talc Pleurodesis Through Indwelling Pleural Catheters for Malignant Pleural Effusions Retrospective Case Series of a Novel Clinical Pathway [J].
Ahmed, Liju ;
Ip, Hugh ;
Rao, Deepak ;
Patel, Nishil ;
Noorzad, Farinaz .
CHEST, 2014, 146 (06) :E190-E194
[3]  
Ak G, 2009, TUBERK TORAK, V57, P22
[4]  
Alamdari DH, 2017, WORLD J SURG
[5]   Autologous Blood Pleurodesis for Persistent Air Leak [J].
Athanassiadi, K. ;
Bagaev, E. ;
Haverich, A. .
THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 (08) :476-479
[6]   Bedside Talc Pleurodesis for Malignant Pleural Effusion: Factors Affecting Success [J].
Aydogmus, Umit ;
Ozdemir, Servet ;
Cansever, Levent ;
Sonmezoglu, Yasar ;
Kocaturk, Celalettin Ibrahim ;
Bedirhan, Mehmet Ali .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (03) :745-750
[7]   Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer [J].
Barbetakis N. ;
Vassiliadis M. ;
Kaplanis K. ;
Valeri R. ;
Tsilikas C. .
BMC Palliative Care, 3 (1)
[8]   Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases [J].
Barbetakis, Nikolaos ;
Asteriou, Christos ;
Papadopoulou, Fani ;
Samanidis, Georgios ;
Paliouras, Dimitrios ;
Kleontas, Athanassios ;
Lyriti, Konstantina ;
Katsikas, Ioannis ;
Tsilikas, Christodoulos .
JOURNAL OF CARDIOTHORACIC SURGERY, 2010, 5
[9]   Early and late mortality after pleurodesis for malignant pleural effusion [J].
Bernard, A ;
de Dompsure, RB ;
Hagry, O ;
Favre, JP .
ANNALS OF THORACIC SURGERY, 2002, 74 (01) :213-217
[10]  
Bethune N., 1935, J THORAC SURG, V4, P251, DOI [10.1016/S0096-5588(20)32384-9, DOI 10.1016/S0096-5588(20)32384-9]